In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deals in Depth: December 2010

Executive Summary

Cephalon's $2.1 billion alliance with Mesoblast for adult mesenchymal precursor stem cells was not only the largest-valued alliance of December, but also the biggest of 2010. M&As in the research tools and diagnostics markets brought in huge numbers including Thermo's $2.1 billion acquisition of Dionex. Publicly raised biopharma money totaled $2.6 billion, thanks to Otsuka's massive IPO. But medical device public fundraising decreased 40% to $148 million.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts